Optimal blood pressure target and measurement in patients with chronic kidney disease
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
The prevalence rates of hypertension and chronic kidney disease (CKD) are increasing with the aging of the population. Hypertension and CKD are closely related, and hypertension with accompanying CKD is difficult to control. This difficulty controlling blood pressure (BP) can be explained by changes in diurnal variation in BP, such as non-dipping and reverse dipping patterns, increased pulse pressure, and BP variability in CKD patients resulting in a high frequency of nocturnal hypertension or masked hypertension. CKD patients with uncontrolled or nocturnal hypertension are at increased risk for cardiovascular disease, progression of CKD, and all-cause death. Recent studies have shown that intensive reduction of systolic BP below 120 mmHg is seems to favor in CKD patients regardless of the presence or absence of diabetes. As BP control is difficult in patients with CKD, appropriate measurement of BP is important. Automated BP monitoring could reduce the so-called “white coat effect” (spike in BP) that may be triggered by measurement in a clinical setting. Moreover, out-of-office BP monitoring at home or ambulatory BP monitoring for 24 hours may provide critical information regarding diurnal BP variability and nocturnal BP in patients with CKD.
Abstract
The prevalence rates of hypertension and chronic kidney disease (CKD) are increasing with the aging of the population. Hypertension and CKD are closely related, and hypertension with accompanying CKD is difficult to control. This difficulty controlling blood pressure (BP) can be explained by changes in diurnal variation in BP, such as non-dipping and reverse dipping patterns, increased pulse pressure, and BP variability in CKD patients resulting in a high frequency of nocturnal hypertension or masked hypertension. CKD patients with uncontrolled or nocturnal hypertension are at increased risk for cardiovascular disease, progression of CKD, and all-cause death. Recent studies have shown that intensive reduction of systolic BP below 120 mmHg is seems to favor in CKD patients regardless of the presence or absence of diabetes. As BP control is difficult in patients with CKD, appropriate measurement of BP is important. Automated BP monitoring could reduce the so-called “white coat effect” (spike in BP) that may be triggered by measurement in a clinical setting. Moreover, out-of-office BP monitoring at home or ambulatory BP monitoring for 24 hours may provide critical information regarding diurnal BP variability and nocturnal BP in patients with CKD.
참고문헌 (44)
- 김현창, "Korea hypertension fact sheet 2018", Clinical Hypertension, 24(4), pp.11~14 (2018), 대한고혈압학회[DOI]
- Hanratty R, "Relationship between blood pressure and incident chronic kidney disease in hypertensive patients", Clin J Am Soc Nephrol, 6, pp.2605~2611 (2011)
- Muntner P, "Hypertension awareness, treatment, and control in adults with CKD : results from the Chronic Renal Insufficiency Cohort(CRIC)Study", Am J Kidney Dis, 55, pp.441~451 (2010)
- Go AS, "Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization", N Engl J Med, 351, pp.1296~1305 (2004)
- Nakayama M, "Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy : the Gonryo study", Hypertens Res, 34, pp.1106~1110 (2011)
- Touyz RM, "Lower is better in hypertension, but how low should blood pressure be targeted?", J Am Soc Hypertens, 10, pp.621~622 (2016)
- Klahr S, "The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group", N Engl J Med, 330, pp.877~884 (1994)
- Wright JT Jr, "Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease : results from the AASK trial", JAMA, 288, pp.2421~2431 (2002)
- Ruggenenti P, "Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease(REIN-2) : multicentre, randomised controlled trial", Lancet, 365, pp.939~946 (2005)
- SPRINT Research Group, "A randomized trial of intensive versus standard blood-pressure control", N Engl J Med, 373, pp.2103~2116 (2015)
- Rocco MV, "Effects of intensive blood pressure treatment on acute kidney injury events in the Systolic Blood Pressure Intervention Trial(SPRINT)", Am J Kidney Dis, 71, pp.352~361 (2018)
- Cheung AK, "Effects of intensive BP control in CKD", J Am Soc Nephrol, 28, pp.2812~2823 (2017)
- Malhotra R, "Effects of intensive blood pressure lowering on kidney tubule injury in CKD : a longitudinal subgroup analysis in SPRINT", Am J Kidney Dis, 73, pp.21~30 (2019)
- Nadkarni GN, "Effect of intensive blood pressure lowering on kidney tubule injury : findings from the ACCORD trial study participants", Am J Kidney Dis, 73, pp.31~38 (2019)
- Walther CP, "Estimated GFR decline and tubular injury biomarkers with intensive blood pressure control", Am J Kidney Dis, 73, pp.4~7 (2019)
- Whelton PK, "2017 ACC", AHA, ABC, pp.ACPM, AGS[DOI]
- Taler SJ, "KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD", Am J Kidney Dis, 62, pp.201~213 (2013)
- Kalaitzidis RG, "Treatment of hypertension in chronic kidney disease", Curr Hypertens Rep, 20, pp.64~ (2018)
- Goto N, "Circadian blood pressure rhythm is disturbed by nephrectomy", Hypertens Res, 28, pp.301~306 (2005)
- Mojon A, "Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease", Chronobiol Int, 30, pp.145~158 (2013)
- Kario K, "Research and development of information and communication technology-based home blood pressure monitoring from morning to nocturnal hypertension", Ann Glob Health, 82, pp.254~273 (2016)
- Pogue V, "Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease", Hypertension, 53, pp.20~27 (2009)
- Agarwal R, "Correlates of systolic hypertension in patients with chronic kidney disease", Hypertension, 46, pp.514~520 (2005)
- Bangash F, "Masked hypertension and whitecoat hypertension in chronic kidney disease : a meta-analysis", Clin J Am Soc Nephrol, 4, pp.656~664 (2009)
- Drawz PE, "Masked hypertension and elevated nighttime blood pressure in CKD : prevalence and association with target organ damage", Clin J Am Soc Nephrol, 11, pp.642~652 (2016)
- Svenningsen P, "Mechanisms of renal NaCl retention in proteinuric disease", Acta Physiol(Oxf), 207, pp.536~545 (2013)
- Thomas G, "BP measurement techniques : what they mean for patients with kidney disease", Clin J Am Soc Nephrol, 13, pp.1124~1131 (2018)
- Velasquez MT, "Ambulatory blood pressure in chronic kidney disease: ready for prime time?", Kidney Int Rep, 1, pp.94~104 (2016)
- Fukuda M, "Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deteriorates in nephropathy", Kidney Int, 65, pp.621~625 (2004)
- Ohashi N, "Circadian rhythm of blood pressure and the renin-angiotensin system in the kidney", Hypertens Res, 40, pp.413~422 (2017)
- Drawz PE, "BP measurement in clinical practice : time to SPRINT to guideline-recommended protocols", J Am Soc Nephrol, 29, pp.383~388 (2018)
- Bakris GL, "The implications of blood pressure measurement methods on treatment targets for blood pressure", Circulation, 134, pp.904~905 (2016)
- Andreadis EA, "Home, automated office, and conventional office blood pressure as predictors of cardiovascular risk", J Am Soc Hypertens, 11, pp.165~170 (2017)
- Stergiou GS, "Validation of the Microlife Watch BP Office professional device for office blood pressure measurement according to the International protocol", Blood Press Monit, 13, pp.299~303 (2008)
- Townsend RR, "Management of hypertension in chronic kidney disease", Nat Rev Nephrol, 11, pp.555~563 (2015)
- Cappuccio FP, "Blood pressure control by home monitoring : meta-analysis of randomised trials", BMJ, 329, pp.145~ (2004)
- Alborzi P, "Home blood pressures are of greater prognostic value than hemodialysis unit recordings", Clin J Am Soc Nephrol, 2, pp.1228~1234 (2007)
- Pickering TG, "Call to action on use and reimbursement for home blood pressure monitoring : executive summary : a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association", Hypertension, 52, pp.1~9 (2008)
- Niiranen TJ, "Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure : the Finn-Home study", Hypertension, 55, pp.1346~1351 (2010)
- de Boer IH, "Diabetes and hypertension : a position statement by the American Diabetes Association", Diabetes Care, 40, pp.1273~1284 (2017)
- Powers BJ, "Measuring blood pressure for decision making and quality reporting: where and how many measures?", Ann Intern Med, 154, pp.781~788 (2011)
- Kanno A, "Night-time blood pressure is associated with the development of chronic kidney disease in a general population : the Ohasama Study", J Hypertens, 31, pp.2410~2417 (2013)
- Parati G, "Prognostic value of blood pressure variability and average blood pressure levels in patients with hypertension and diabetes", Diabetes Care, 36, pp.S312~S324 (2013)
- Pickering TG, "Ambulatory blood-pressure monitoring", N Engl J Med, 354, pp.2368~2374 (2006)